GLP-1 Sublingual Drops

starting at $199/mo


FSA/HSA eligible

Free shipping

GLP-1 (Semaglutide) medications are designed to work like a natural hormone in your body that regulates appetite and blood sugar. GLP-1 mimics one hormone that can help you feel satisfied longer, slow digestion, and curb hunger to support weight management for some people when used with provider guidance and healthy habits.

Potential Benefits

  • Decreases appetite and reduces cravings

  • Promotes weight loss

  • Lowers A1C levels (a marker of blood sugar control)

  • Improves cardiometabolic health measures

  • Enhances insulin sensitivity

  • Reduces Inflammation

  • GLP-1: Semaglutide (concentration varies)

    90 day supply

    If approved, appropriate dose will be determined by a licensed healthcare provider during your complimentary online exam.

  • Medication is designed for absorption into the bloodstream via sublingual route, which may allow systemic delivery without passing through the GI tract. Individual absorption may vary.

    Sublingual drops are placed under the tongue, typically taken daily.

    GLP-1 medications act on areas of the brain and digestive system to:
    • Reduce appetite and cravings
    • Slow digestion so you feel full longer
    • Improve blood sugar control

    GLP-1 (Semaglutide) is a single-action therapy that mimics one hormone:

    GLP-1 (glucagon-like peptide-1):
    • Reduces appetite and cravings
    • Slows digestion so you feel full longer
    • Improves blood sugar control

  • What are GLP-1 medications?
    GLP-1 medications are prescription therapies that mimic natural hormones involved in appetite and blood sugar regulation. They help you feel fuller longer, reduce cravings, and support healthier eating patterns as part of a provider-guided wellness plan.

    What are GLP-1 medications used for?
    They’re commonly used to support weight management and metabolic health when combined with lifestyle changes like nutrition, movement, and sleep.

    How do GLP-1s work in the body?
    GLP-1s act on areas of the brain and digestive system to:
    • Reduce appetite and cravings
    • Slow digestion so you feel full longer
    • Improve blood sugar control

    How long does it take to see results?
    Benefits like appetite reduction and weight changes may be noticed within a few weeks, but individual responses vary based on dose, consistency, and personal biology.

    Can I use this with other medications?
    GLP-1s can be used with many medications, but they should NOT be used with other GLP-1 therapies. Always tell your provider about all medications and supplements you’re taking so they can review for interactions.

    How does a GLP-1 (Semaglutide) differ from a GIP/GLP-1 (Tirzepatide)?
    GLP-1 (Semaglutide) is a single-action therapy that mimics one hormone:

    GLP-1 (glucagon-like peptide-1):
    • Reduces appetite and cravings
    • Slows digestion so you feel full longer
    • Improves blood sugar control

    GIP/GLP-1 (Tirzepatide) is a dual-action therapy that mimics two hormones:

    GLP-1 (glucagon-like peptide-1):
    • Reduces appetite and cravings
    • Slows digestion so you feel full longer
    • Improves blood sugar control

    GIP (glucose-dependent insulinotropic polypeptide):
    • Further supports insulin response
    • May enhance fat metabolism and appetite control

    Because it targets two pathways instead of one, tirzepatide may lead to greater weight changes, stronger blood sugar improvements, and more appetite suppression for some people.

    Q. How are GLP-1 drops taken?
    A. GLP-1 sublingual drops are taken under the tongue, typically daily.

    Are there side effects?
    Please refer to the medication information linked on this page.

    Who should NOT use GLP-1?
    Please refer to the medication information linked on this page. Make sure to discuss your current medications and health history with your provider to see if this medication is appropriate for you.

    How long will I stay on a GLP-1?
    There’s no one-size-fits-all timeline. Your provider will monitor your progress and adjust your plan over time based on your goals and response.

    Is GLP-1 FDA-approved?
    Brand-name versions of semaglutide and tirzepatide are FDA-approved for certain indications. Compounded versions are prescribed by licensed providers and dispensed by state-licensed pharmacies in accordance with regulations.

Disclaimer: Products are only available if prescribed after an online consultation with a licensed healthcare provider. Compounded medications are dispensed by third-party USA licensed pharmacies. The Food and Drug Administration does not review compounded medications for safety or effectiveness and the statements on this page have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent diseases. Results may vary. Discontinue use and seek care if you if you experience any adverse reaction to this product. Product is offered by subscription which you can cancel anytime. Photo is for illustration purposes; actual packaging may differ.

Related Products:

GLP-1 Injection

MIC+B12

B12 Nasal Spray

GLP-1 Benefits

Do sublingual medications really work?

These delivery methods are well known in medicine.

Sublingual drops are absorbed through the oral mucosa under the tongue. This area is rich in blood vessel networks, which may allow medication to enter systemic circulation and bypass the gut.

These routes are widely used in healthcare. For example, medications such as sublingual nitroglycerin use this pathway for rapid delivery.

While injectable medications often provide high bioavailability, sublingual drops offer a needle-free alternative.

Rely on Birdie for elevated needle-free options. No needles. Just progress.

Disclaimer: The effectiveness of any medication depends on the specific drug, formulation, and individual patient factors. Results may vary and are not guaranteed.

GLP-1 (semaglutide)

VS

GLP-1+GIP (tirzepatide)

Single-action therapy that mimics 1 hormone:

GLP-1 (glucagon-like peptide-1):

  • Reduces appetite and cravings

  • Slows digestion so you feel full longer

  • Improves blood sugar control

GLP-1 (semaglutide)

Dual-action therapy that mimics 2 hormones:

GLP-1 (glucagon-like peptide-1):

  • Reduces appetite and cravings

  • Slows digestion so you feel full longer

  • Improves blood sugar control

    GIP (glucose-dependent insulinotropic polypeptide) further supports insulin response and may enhance fat metabolism and appetite control

  • Because it targets two pathways instead of one, it may lead to greater weight loss, stronger blood sugar improvements, and greater appetite suppression.

GLP-1+GIP (tirzepatide)

Rise into a lighter you.

GLP-1

Lighten your body, elevate your life.

GLP-1 helps support appetite control and metabolic balance so you can feel lighter, clearer, and empowered in your body.

Formats to fit your lifestyle:

Sublingual Drops: daily, easy

Injection: Fast-acting

High-level care, wherever you are.

24/7 Online provider support

Manage treatments online

Free delivery to your door

You may also be interested in

MIC+B12

How Birdie Online Works

  • Step 1

    HEALTH QUESTIONNAIRE

    Complete a no-obligation form online about your health history and goals for treatment.

  • Step 2

    COMPLIMENTARY EVALUALTION

    Meet with a licensed healthcare provider 100% online to see if you qualify for a treatment plan.

  • Step 3

    FAST & FREE SHIPPING

    If approved, your prescription will ship directly to you. Get regular online check-ins and support.

High Standards. High Quality.

Birdie partners with licensed pharmacies to provide lab-tested, quality medications.

  • Compounded in the U.S.A.

  • Third-party tested for quality control

Popular Products

Hormone

Therapy

for women

Coming Soon

Designed to elevate.

Grounded in research.

Research is our passion- check out some GLP-1 articles:

Chao, A. M., Tronieri, J. S., Amaro, A., & Wadden, T. A. (2022). Clinical insight on semaglutide for chronic weight management in adults: Patient selection and special considerations. Drug Design, Development and Therapy, 16, 4449–4461. https://doi.org/10.2147/DDDT.S365416

Khoo, T. K., & Lin, J. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 385(1), e4. https://doi.org/10.1056/NEJMc2106918

Lexicomp Online. (2025). Semaglutide: Drug information. Lexi-Drugs database. Wolters Kluwer. https://online.lexi.com/lco/action/doc/retrieve/docid/patch_f/6577162

Lincoff, A. M., Brown-Frandsen, K., Colhoun, H. M., Deanfield, J., Emerson, S. S., Esbjerg, S., Hardt-Lindberg, S., Hovingh, G. K., Kahn, S. E., Kushner, R. F., Lingvay, I., Oral, T. K., Michelsen, M. M., Plutzky, J., Tornøe, C. W., & Ryan, D. H. (2023). Semaglutide and cardiovascular outcomes in obesity without diabetes. New England Journal of Medicine, 389(24), 2221–2232. https://doi.org/10.1056/NEJMoa2307563